Evolent Health (EVH) Notes Payables (2023 - 2025)

Evolent Health's (EVH) quarterly Notes Payables came in at $5.1 million in Q3 2025, down 97.03% quarter-over-quarter from $172.1 million in Q2 2025.

Evolent Health (EVH) Notes Payables (2023 - 2025) Analysis & Trends

Evolent Health's Notes Payables history runs 3 years deep, the most recent figure standing at $5.1 million for Q3 2025.

  • On a quarterly basis, Notes Payables changed N/A year-over-year to $5.1 million in Q3 2025; TTM through Sep 2025 was $5.1 million, a N/A change from a year earlier, with the FY2024 full-year figure at $171.5 million, changed N/A from the prior year.
  • Notes Payables fell to $5.1 million in Q3 2025 per EVH's latest filing, from $172.1 million in the prior quarter.
  • Across five years, Notes Payables topped out at $172.1 million in Q2 2025 and bottomed at $991000.0 in Q3 2023.
  • The 3-year median for Notes Payables is $171.5 million (2024), against an average of $104.3 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn
9 Privia Health 3.10 Bn 2.73 Bn -
10 Evolent Health 517.00 Mn 351.02 Mn 83.77 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 5.12 Mn
Jun 30, 2025 172.12 Mn
Mar 31, 2025 171.79 Mn
Dec 31, 2024 171.47 Mn
Sep 30, 2023 991,000.00